Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19

BACKGROUND: Neutralizing monoclonal antibodies (MAbs) are a promising therapy for early coronavirus disease 2019 (COVID-19), but their effectiveness has not been confirmed in a real-world setting. METHODS: In this quasi-experimental pre-/postimplementation study, we estimated the effectiveness of MA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Webb, Brandon J, Buckel, Whitney, Vento, Todd, Butler, Allison M, Grisel, Nancy, Brown, Samuel M, Peltan, Ithan D, Spivak, Emily S, Shah, Mark, Sakata, Theadora, Wallin, Anthony, Stenehjem, Eddie, Poulsen, Greg, Bledsoe, Joseph
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Major Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314951/
https://ncbi.nlm.nih.gov/pubmed/34327256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab331
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados